HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuki Terashima Selected Research

Heavy Ion Radiotherapy

9/2023Carbon-ion radiotherapy for oligometastatic liver disease: A national multicentric study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).
12/2021Predicted probabilities of brain injury after carbon ion radiotherapy for head and neck and skull base tumors in long-term survivors.
9/2020Phase I dose-escalation trial of S-1 combined with carbon-ion radiotherapy for sinonasal squamous cell carcinoma.
1/2019Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS).
12/2018Short-course carbon-ion radiotherapy for hepatocellular carcinoma: A multi-institutional retrospective study.
11/2018Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study.
1/2018Outcomes of Patients With Sinonasal Squamous Cell Carcinoma Treated With Particle Therapy Using Protons or Carbon Ions.
11/2015Unexpected radiation laryngeal necrosis after carbon ion therapy using conventional dose fractionation for laryngeal cancer.
7/2014Two-stage treatment with hepatectomy and carbon-ion radiotherapy for multiple hepatic epithelioid hemangioendotheliomas.
5/2014Particle radiotherapy using protons or carbon ions for unresectable locally advanced head and neck cancers with skull base invasion.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuki Terashima Research Topics

Disease

21Neoplasms (Cancer)
03/2024 - 10/2009
13Hepatocellular Carcinoma (Hepatoma)
03/2024 - 07/2011
7Pancreatic Neoplasms (Pancreatic Cancer)
08/2023 - 04/2012
4Thrombosis (Thrombus)
03/2024 - 07/2011
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2015 - 05/2010
3Neoplasm Metastasis (Metastasis)
08/2023 - 04/2012
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2020 - 11/2015
2Cholangiocarcinoma
04/2024 - 01/2019
2Liver Neoplasms (Liver Cancer)
03/2024 - 09/2021
2Brain Injuries (Brain Injury)
12/2021 - 10/2009
2Prostatic Neoplasms (Prostate Cancer)
01/2021 - 10/2017
2Sarcoma (Soft Tissue Sarcoma)
01/2020 - 01/2017
2Chordoma
11/2018 - 01/2018
2Necrosis
07/2016 - 11/2015
2Inflammation (Inflammations)
07/2016 - 11/2015
2Head and Neck Neoplasms (Head and Neck Cancer)
05/2014 - 10/2009
2False Aneurysm (Pseudoaneurysm)
12/2013 - 08/2004
1Liver Diseases (Liver Disease)
09/2023
1Biliary Tract Neoplasms (Biliary Tract Cancer)
07/2023
1Klatskin Tumor
01/2022
1Ulcer
01/2021
1Adenocarcinoma
08/2019
1Laryngeal Neoplasms (Laryngeal Cancer)
11/2015
1Laryngeal Edema
11/2015
1Pain (Aches)
11/2015
1Pathologic Constriction (Stenosis)
11/2015
1Squamous Cell Carcinoma of Head and Neck
11/2015
1Lung Neoplasms (Lung Cancer)
03/2015
1Adenoid Cystic Carcinoma (Cylindroma)
12/2014
1Epithelioid Hemangioendothelioma
07/2014
1Jaundice (Icterus)
12/2013
1Hemobilia
12/2013
1Colorectal Neoplasms (Colorectal Cancer)
12/2013
1Acute Abdomen
12/2013
1Hemorrhage
04/2012
1Stomach Ulcer (Gastric Ulcer)
04/2012
1Optic Nerve Diseases (Optic Neuropathy)
12/2009
1Penetrating Wounds (Penetrating Wound)
08/2004

Drug/Important Bio-Agent (IBA)

17Protons (Proton)IBA
08/2023 - 12/2009
11CarbonIBA
09/2023 - 12/2009
6IonsIBA
01/2018 - 05/2014
4GemcitabineFDA Link
02/2022 - 04/2012
3serum P-component (CIt)IBA
11/2018 - 10/2013
1atezolizumabIBA
03/2024
1Bevacizumab (Avastin)FDA Link
03/2024
1ProdrugsIBA
04/2021
1Acrolein (Aqualin)IBA
04/2021
1AntigensIBA
08/2019
1ferric oxide (iron oxide)IBA
06/2017
1Polytetrafluoroethylene (Teflon)FDA Link
06/2017
1gadolinium ethoxybenzyl DTPAFDA Link
01/2016
1CyanoacrylatesIBA
12/2013
1Panitumumab (Vectibix)FDA Link
12/2013
1P-2 (P 2)IBA
04/2012
1PlatinumIBA
08/2004

Therapy/Procedure

22Therapeutics
03/2024 - 10/2009
19Radiotherapy
03/2024 - 12/2009
16Heavy Ion Radiotherapy
09/2023 - 10/2009
15Proton Therapy
04/2024 - 10/2009
4Drug Therapy (Chemotherapy)
04/2024 - 12/2013
3Hepatectomy
09/2021 - 11/2011
1Liver Transplantation
01/2023
1Radiofrequency Ablation
01/2023
1Pancreatectomy
08/2019
1Pancreaticoduodenectomy
08/2019
1Aftercare (After-Treatment)
07/2016
1Laryngectomy
11/2015
1Stents
12/2013
1Catheters
08/2004